Who is sponsoring NCT03407898?

NCT03407898 is sponsored by Ankara University.

What drugs are being tested in NCT03407898?

Interventions in NCT03407898: intubation time.

What condition does NCT03407898 study?

NCT03407898 studies Mallampati Score, Difficult Intubation, Videolaryngoscope.

Is NCT03407898 still recruiting?

NCT03407898 is currently completed. Last updated 28 February 2020.

Last reviewed 2020-02-28 · How we verify

NCT03407898

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Different Videolaryngoscopes on Intubation Success in Difficult Airway Patients

Completed Last updated 28 February 2020

What this trial tests

trial testing intubation time in Mallampati Score, Difficult Intubation, Videolaryngoscope in 130 participants. Completed in 1 November 2018.

Timeline

2 May 2018

Primary endpoint
1 September 2018

1 November 2018

Quick facts

Lead sponsor	Ankara University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	130
Start date	2 May 2018
Primary completion	1 September 2018
Estimated completion	1 November 2018
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

intubation time

Conditions studied

Mallampati Score, Difficult Intubation, Videolaryngoscope — all drugs for Mallampati Score, Difficult Intubation, Videolaryngoscope →

Sponsor

Ankara University

Who can join

Adults 18 to 65, any sex, with Mallampati Score, Difficult Intubation, Videolaryngoscope. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Mallampati score \> 3 generally indicate difficult airway and difficult intubation. Most anesthesiologist usually use this score system to predict difficult airway management. Different laryngoscopes may be useful in management of difficult airway. This study designed to compare different videolaryngoscopes in intubation success in patient of Mallampati score\>3.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ankara University trials

Trials by the same sponsor.

NCT07441837 — Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients · Phase 2 · not yet recruiting
NCT07536490 — Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease · not yet recruiting
NCT06959433 — Lu-177 PSMA Treatment in Cell Renal Carcinoma · Phase 3 · not yet recruiting
NCT07513272 — EFFECT OF BALLS ON PAIN AND ANXIETY DURING VENIPUNCTURE IN CHILDREN · NA · not yet recruiting
NCT07536542 — Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03407898 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara University
Last refreshed: 28 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03407898.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing